Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Transmembrane serine protease 11B (TMPRSS11B) is a cell surface serine protease involved in proteolytic processes in epithelial tissues. TMPRSS11B is highly expressed in the plasma membrane and enhances lactate export by promoting the solubilization of Basigin, the chaperone for the monocarboxylate transporter MCT4, leading to increased glycolytic metabolism in cancer cells. This activity is crucial for tumorigenesis in lung squamous cell carcinoma, and high TMPRSS11B expression correlates with poor prognosis in lung cancer patients. TMPRSS11B may be a novel therapeutic target in cancer, especially because it is accessible on the cell membrane and functionally linked to metabolic pathways[1][3][8][9].
Inhibition of serine protease activity (by aforementioned inhibitors)[9]. Potential interruption of metabolic reprogramming in cancer cells by blocking the solubilization of Basigin and subsequent lactate export[1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Transmembrane serine protease 11B (TMPRSS11B).